Journal Guide

Biomarkers in Medicine is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice. As the scientific rationale and regulatory acceptance for biomarkers in medicine and in drug development become more fully established, Biomarkers in Medicine provides the platform for all players in this increasingly vital area to communicate and debate all issues relating to the potential utility and applications.

Biomedical Chromatography is devoted to the publication of original papers on the applications of chromatography and allied techniques in the biological and medical sciences. Research papers and review articles cover the methods and techniques relevant to the separation, identification and determination of substances in biochemistry, biotechnology, molecular biology, cell biology, clinical chemistry, pharmacology and related disciplines. These include the analysis of body fluids, cells and tissues, purification of biologically important compounds, pharmaco-kinetics and sequencing methods using HPLC, GC, HPLC-MS, TLC, paper chromatography, affinity chromatography, gel filtration, electrophoresis and related techniques. This journal, as well as reporting current research, also serves our community as a major resource for information on practical and instrumental methodology.

An international multidisciplinary journal with two objectives:- to create an interface between clinical and laboratory responses to drugs and to investigate critical approaches to different pathologies with regard to biological and clinical data,- to provide a niche for authors whose work is not directly defined by the review criteria of existing journals.Biomedicine and pharmacotherapy is one of the few journals at the forefront of fundamental and technical science, biological and medical disciplines, therapeutics and pathological description. General fields of interest include molecular and cell biology, genetic disease, immunology and immunoregulation and chemotherapy. Special emphasis is placed on studies of specific topics such as differentiation, pharmacology and toxicology, preclinical and clinical pharmacology, the effects of drugs on cell structural and functional elements, the mechanism of gene regulation in normal and pathological cells, the role of viruses and parasites and the therapy of the diseases they induce. Brief reports of meetings, symposia and conferences will also be considered for publication as well as announcements of scientific meetings or academic courses.

Bioorganic Chemistry publishes accounts of research that provide mechanistic insight inspired by Biology. The guiding principle that the Editorial Board will follow in accepting manuscripts for publication is that the research uses the principles and techniques of organic and physical organic chemistry in attempting to solve some problem of relevance to biology or that are directly inspired by some biological observation.Within this context, manuscripts suitable for submission are ones that deal with such topics as enzymology and biocatalysis (including the study of ribozymes and catalytic antibodies), closely-relevant enzyme models, biosynthesis and combinatorial biosynthesis, and biomimetic synthesis. In addition, the theoretical treatment of any of these topics is appropriate, as is the application of biophysical and analytical techniques to advance our understanding of one of these topics. The Journal publishes regular articles, preliminary communications, reviews and mini-reviews.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Bioorganic & Medicinal Chemistry provides an international forum for the publication of full original research papers and critical reviews on molecular interactions in key biological targets such as receptors, channels, enzymes, nucleotides, lipids and saccharides.The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. A special feature will be that colour illustrations will be reproduced at no charge to the author, provided that the Editor agrees that colour is essential to the information content of the illustration in question.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Bioorganic & Medicinal Chemistry Letters presents preliminary experimental or theoretical research results of outstanding significance and timeliness on all aspects of science at the interface of chemistry and biology and on major advances in drug design and development. The journal publishes articles in the form of communications reporting experimental or theoretical results of special interest, and strives to provide maximum dissemination to a large, international audience.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Biopharmaceutics & Drug Dispositionpublishes original review articles, short communications, and reports in biopharmaceutics, drug disposition, pharmacokinetics and pharmacodynamics, especially those that have a direct relation to the drug discovery/development and the therapeutic use of drugs. These includes: * animal and human pharmacological studies that focus on therapeutic response. pharmacodynamics, and toxicity related to plasma and tissue concentrations of drugs and their metabolites, * in vitro and in vivo drug absorption, distribution, metabolism, transport, and excretion studies that facilitate investigations related to the use of drugs in man * studies on membrane transport and enzymes, including their regulation and the impact of pharmacogenomics on drug absorption and disposition, * simulation and modeling in drug discovery and development * theoretical treatises * includes themed issues and reviews and exclude manuscripts on * bioavailability studies reporting only on simple PK parameters such as Cmax, tmax and t1/2 without mechanistic interpretation * analytical methods Reports must contain current citation of the literature and convey new information. Biopharmaceutics & Drug Disposition is one of the top accessed and cited journals in the field, as a result of the high quality papers published in the journal, and is marketed by Wiley Blackwell across the world.

Biotechnology and Applied Biochemistry has been published continuously since its creation in 1986 (previous to that date it was called the Journal of Applied Biochemistry and was published from 1979 to 1985). Today it enjoys a superb track record, attracting distinguished authors from academia and industry from all over the world, reflecting its international status. Biotechnology and Applied Biochemistry is now published bi-monthly by Wiley-Blackwell, confirming the journal's dedication to change and commitment to rapid publication of high-quality, cutting-edge research at the interface between life sciences and their translation. It publishes new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences. Promising advances in life sciences are leading to the identification of the molecular sources of disease and the creation of new generation of medicines for diseases for which there are currently either no therapies or inadequate treatments. Therapeutic proteins and antibodies are already having a significant impact in treatment of disease. Therapeutic genes and viruses promise to have an even bigger impact on human healthcare. DNA vaccine and gene-therapy are under intense development and new research areas such as tissue engineering, stem-cell therapeutics, germ-line therapy and regenerative medicines are expected to create a new wave of medicines that will make today's treatment of diseases look distinctively primitive. All this provides major challenges to life scientists and engineers engaged in discoveries and their translation to practical outcomes. Turning a new discovery into a successful application has become a highly integrated, multidisciplinary activity, and Biotechnology and Applied Biochemistry is uniquely placed to provide an international forum for the dissemination of information and discussion by researchers working across the many subject groups. The journal welcomes submissions of original articles on the following topics: nucleic acids and proteins engineering and purification; genes peptides and proteins therapy; biomaterials; biological modeling; stem cells and tissue engineering; bio-imaging; bio-sensors; biotechnology of food and natural compounds. Original papers and reviews as well as special issues can be also invited by the Editorial Board. Papers are easily submitted online at: http://mc.manuscriptcentral.com/bab.

The purpose of this journal is to publish original contributions describing the toxicity of chemicals to developing organisms and the process of reproduction. The scope of the journal will inlcude:• toxicity of new chemical entities and biotechnology derived products to developing organismal systems; .

Reports on all aspects of drug action in humansOriginal papers. reviews. editorials. letters. book reviewsNorth American. European. Australasian EditorsSpecial supplements on new drugsOpen-access after 12 monthsOnline submission through ScholarOne Manuscripts Published on behalf of the British Pharmacological Society Aims and Scope Published on behalf of the British Pharmacological Society. theBritish Journal of Clinical Pharmacologycontains papers and reports on all aspects of drug action in humans: invited review articles. original papers. short communications and correspondence. The Journal enjoys a wide readership. bridging the gap between the medical profession. clinical research and the pharmaceutical industry. Proceedings of the meetings of the Clinical Section of the British Pharmacological Society are published in abstract form. and supplements containing information on new methods. new drugs and new approaches to treatment are supplied free of charge. All editorials now available to access free online. Clickhere to access now! Readership The journal contains research and review articles on all aspects of drug action in humans. together with abstracts of clinical proceedings of the Society. The journal is recognized as one of the leading publications in its field. The readership consists of clinical pharmacologists in academic and NHS posts. pharmacologists. pharmacists. physicians as well as scientists in the pharmaceutical industry. The readership reflects the journal"s role as a bridge between the medical professions. clinical research and the pharmaceutical industry.

2009 Impact Factor: 5.204* BJPis the highest ranked general pharmacology research journal. now ranked 19th in the ISI Pharmacology and Pharmacy category* * Thomson Reuters Science Citation Index 2009 Aims and Scope TheBritish Journal of Pharmacology(BJP) is a broad-based journal giving leading international coverage of all aspects of experimental pharmacology. Its scope includes: Anti-infective drugs Biopharmaceuticals Cancer pharmacology Cardiovascular pharmacology Drug discovery Drug safety and toxicology Endocrine and metabolic pharmacology Gastrointestinal pharmacology Genitourinary and renal pharmacology Immunopharmacology and Inflammation Molecular and cellular mechanisms Neuropharmacology Pharmacokinetics and drug metabolism Respiratory system pharmacology Methods and techniques Social impact of pharmacology Readership Pharmacologists; toxicologists; pharmaceutical researchers; medicinal chemists; molecular biologists; physiologists; neuroscientists; target discovery and drug discovery researchers. pharmacists; clinicians. Keywords British Journal of Pharmacology. BJP. journal. pharmacology. pharmacological. drugs. therapeutics. medicinal chemistry. pharmaceutical medicine. experimental pharmacology. translational research. biopharmaceuticals. drug discovery. drug safety. pharmacokinetics and drug metabolism. toxicology. neuropharmacology. cardiovascular pharmacology. respiratory pharmacology. immunopharmacology. cancer. endocrine pharmacology. GRAC. receptors. channels. transporters. G-protein coupled receptors. antagonist. agonist. drug targets. target discovery. drug design. pharma. pharmaceutical research. British Pharmacological Society.

The Bulletin of Environmental Contamination and Toxicology provides rapid publication of peer-reviewed articles describing significant advances and discoveries in the fields of air, soil, water, and food contamination and pollution as well as articles on methodology and other disciplines concerned with the introduction, presence and effects of toxicants in the total environment. With its high standards of scientific quality and clarity, the Bulletin provides a meeting ground for research workers who daily encounter problems related to the contamination of our environment and who welcome opportunities to share in new discoveries as soon as they are made.

The Bulletin of Mathematical Biology is devoted to research at the junction of computational, theoretical and experimental biology. Articles offer a combination of theory and experiment, documenting theoretical advances with clear exposition of how they further biological understanding. Its aim is to be of major interest to theorists and experimental biologists alike.The Bulletin of mathematical biology also invites submissions of review articles which offer an in-depth treatment of an emerging research area, or a significant recent development, in the general area of computational, theoretical and mathematical biology. Those interested in writing such a review article should contact James Sneyd at sneyd@math.auckland.ac.nz This is the official journal of the Society for Mathematical Biology.

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes.

Published since 1929, this monthly journal reports current research in all aspects of physiology, nutrition, pharmacology, and toxicology, contributed by recognized experts and scientists. It publishes symposium reviews and award lectures and occasionally dedicates entire issues or portions of issues to subjects of special interest to its international readership. The journal periodically publishes a “Made In Canada” special section that features invited review articles from internationally recognized scientists who have received some of their training in Canada.

Cancer, the second leading cause of death, is a heterogenous group of over 100 diseases. Cancer is characterized by disordered and deregulated cellular and stromal proliferation accompanied by reduced cell death with the ability to survive under stresses of nutrient and growth factor deprivation, hypoxia, and loss of cell-to-cell contacts. At the molecular level, cancer is a genetic disease that develops due to the accumulation of mutations over time in somatic cells. The phenotype includes genomic instability and chromosomal aneuploidy that allows for acceleration of genetic change. Malignant transformation and tumor progression of any cell requires immortalization, loss of checkpoint control, deregulation of growth, and survival. A tremendous amount has been learned about the numerous cellular and molecular genetic changes and the host-tumor interactions that accompany tumor development and progression. It is the goal of the field of Molecular Oncology to use this knowledge to understand cancer pathogenesis and drug action, as well as to develop more effective diagnostic and therapeutic strategies for cancer. This includes preventative strategies as well as approaches to treat metastases. With the availability of the human genome sequence and genomic and proteomic approaches, a wealth of tools and resources are generating even more information. The challenge will be to make biological sense out of the information, to develop appropriate models and hypotheses and to translate information for the clinicians and the benefit of their patients. Cancer Biology & Therapy aims to publish original research on the molecular basis of cancer, including articles with translational relevance to diagnosis or therapy. We will include timely reviews covering the broad scope of the journal. The journal will also publish op-ed pieces and meeting reports of interest. The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats. The journal and the outstanding Editorial Board will strive to maintain the highest standards for excellence in all activities to generate a valuable resource.